# Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes

> **NCT00825643** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 18481 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin detemir

## Key facts

- **NCT ID:** NCT00825643
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 18481 (ACTUAL)
- **Last updated:** 2017-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00825643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00825643, "Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00825643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*